Home
BeiGene

BeiGene Market Share Analysis for November 2025

BeiGene, Ltd. is a China-based drug developer. It specializes in the development of drugs for cancer treatment.

Health > Biotechnology and Pharmaceuticals

Domainbeigene.com

Year Founded2010

Employees> 10001

Annual Revenue> $1B

BeiGene

BeiGene (including company regionals)

beigene.com

See more website traffic and engagement information

BeiGene Revenue up to November 2025 is > 1B

revenue generated by BeiGene top domains

BeiGene top domains revenue over 3 years

Revenue for BeiGene top domains

beigene.com> 1B

See more with Sales Intelligence

BeiGene Stock price in November 2025

BeiGene stock is traded under the ticker #BGNE. Below you can review BeiGene stock performance in the past 12 months up to November 2025

Total visits to BeiGene's top domains

Understand BeiGene market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

beigene.com5.3K

See more with Sales Intelligence

Avg. visit duration in BeiGene's top domains

Analyze BeiGene engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

beigene.com00:00:02

See more with Sales Intelligence

Avg. pageviews on BeiGene's top domains

See how BeiGene keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

beigene.com2.80

See more with Sales Intelligence

BeiGene top competitors by domain

Top similar sites in November 2025, ranked by their affinity

beonemedicines.comCompany NameBeOne MedicinesEmployees> 10001HQUnited States, CambridgeAnnual revenue--Total visits32.3KHealth > Biotechnology and Pharmaceuticals

Top technologies used by BeiGene

These are the website technologies, by industry, used by BeiGene top domains

Advertising (8)

DoubleClick

Social (6)

Instagram

Widget (6)

Twemoji

Marketing (5)

Google Marketing Platform

More Technologies

14

See all

News & Signals from BeiGene

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsBeiGene Ltd. attends event European Hematology Association (EHA) Congress.Sino-American oncology company BeOne Medicines (Nasdaq: ONC), previously called BeiGene, is presenting new clinical data from cornerstone hematology assets at the European Hematology Association (EHA) Congress.

NewsBeiGene Ltd. had issues with patent infringement lawsuit on Nov 1st '23.On November 1, 2023, BeiGene filed a PGR petition with the USPTO challenging the validity of certain claims of the '803 patent, in response to a patent infringement lawsuit Pharmacyclics brought against BeiGene concerning BRUKINSA(R) (zanubrutinib).

Newsnference partnered with BeiGene Ltd. on Apr 24th '25.NEW YORK - nFerence on Thursday said it has partnered with BeiGene to study treatment patterns and outcomes in B-cell cancers using nFerence's Agentic artificial-intelligence platform.